To advance the development of diagnostic tools and new treatments for patients with neurodegenerative conditions through clinical research. The hope for a cure is through clinical research. The Institute for Neurodegenerative Disorders (IND), founded in 2001, is an independent 501(c)3 nonprofit research institute based in New Haven, Connecticut. Its team of expert researchers includes neurologists, nurses, study coordinators, neuropsychologists, and nuclear medicine technologists working together to accomplish IND's mission.
Services
There are numerous opportunities at IND for patients to participate in a variety of research studies. During the past year, over 1,000 individuals participated in our research program. While many of these research participants are from New England, nearly half of our participants travel from throughout the United States and Canada to play a part in our research program. This is a very exciting period for neurological research with many new therapies being evaluated in clinical studies and many more in the pipeline.
The Institute for Neurodegenerative Disorders (IND), founded in 2001, is an independent 501(c)3 nonprofit research institute based in New Haven, Connecticut. The company was founded in 2001 by Drs. Kenneth Marek and John Seibyl, who had previously established their collaboration while on the faculty at Yale University.
IND is comprised of an accomplished team of physician investigators, study coordinators, neuropsychologists and imaging technologists. Our Board of Directors provides invaluable support and oversight. Dr. Marek co-founded IND in 2001 and serves as IND's Distinguished Scientist and Treasurer. Dr. Marek served as President of IND from its founding through 2018.
There are numerous opportunities at IND for volunteers to participate in a variety of research studies. During the past year, hundreds of individuals participated in our research program. Some volunteers are effected by Parkinson's Disease or Alzheimer's Disease and want to help researchers find out more about it in order to develop new treatments.
Reviews (1)
Annastacia Mokgosi
Dec 28, 2019
